Treatment of lymphedema and related conditions using placental adherent cells
AssigneeCelularity Inc.
InventorsRobert J. Hariri, Shuyang He
Life of this patent
Estimating the term…
Abstract
Provided herein are methods of using tissue culture plastic-adherent placental adherent cells, e.g. placental stem cells, referred to herein as placental adherent cells, to treat lymphedema and lymphedema-related disorders.
Claims24
A method of treating an individual having lymphedema, or a disease or disorder caused by lymphedema, comprising administering to the individual a therapeutically effective amount of placental adherent cells, wherein said therapeutically effective amount is an amount sufficient to reduce or ameliorate one or more symptoms or sequelae of said lymphedema or disease or disorder caused by lymphedema, in said individual, as compared to the individual prior to said administering.
Dependencies are inferred from the claim text.